Curio Bioscience v 10x Genomics (CFI, 23 April 2024)
| Date | 23 April 2024 |
|---|---|
| Court | CFI |
| Division | Düsseldorf (DE) Local Division |
| Type of action | Generic Order |
| Registry reference | ORD_22211/2024 |
| Parties | Curio Bioscience Inc. v. 10x Genomics, Inc. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By an order of 23 April 2024 (UPC_CFI_463/2023, ACT_590953/2023, ORD_22211/2024), presiding judge Thomas, acting as judge-rapporteur of the Düsseldorf Local Division, allowed the division to issue its orders and decisions in German with a certified English translation, in the provisional measures proceedings brought by 10x Genomics, Inc. against Curio Bioscience Inc. on EP 2 697 391 B1. The Court of Appeal had just made English the language of the proceedings, although the whole case, including the oral hearing, had been conducted in German. The order shows how a local division deals with the practical consequences of a late change of language.
Question
Once the Court of Appeal has changed the language of the proceedings to English, may the judge-rapporteur allow the division to rule in German with a certified English translation?
Decision
Yes. Germany has designated English as an additional language of proceedings for its local divisions and has made the indication contemplated by Rule 14.2(c) RoP, which allows the judge-rapporteur to permit decisions in German accompanied by a certified translation. The division used that option exceptionally: the language changed on 17 April 2024, less than two weeks before the scheduled date of the order, the case is complex, the entire procedure was conducted in German and work on the final order had already begun. Building on that work avoids unnecessary delay. The certified translation serves the purposes of Rule 118.8 RoP.
Key points for practice
- Practical point: a change of language obtained late on appeal does not necessarily force the division to draft its decision in the new language, Rule 14.2(c) RoP allows it to rule in the language of the Member State with a certified translation.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 49(1) and (2)
- Rules of Procedure
- Rules 14.1(a), 14.1(b), 14.2(c) and 118.8
- Case law cited
- Curio Bioscience v 10x Genomics, Court of Appeal, 17 April 2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- defendant10x Genomics, Inc.57 decisions in the corpusFollow this party
- claimantCurio Bioscience Inc.29 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic Order
- Outcome (Dhenne Avocats summary)
- La division locale de Düsseldorf est autorisée à rendre ses ordonnances et décisions en allemand, avec traduction certifiée en anglais, après le passage de la procédure à l'anglais décidé par la cour d'appel.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 697 391mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Curio Bioscience v 10x Genomics (CoA, 17 April 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 697 391Method and product for localised or spatial detection of nucleic acid in a tissue sample recorded proprietor: Spatial Transcriptomics AB | Mentioned in the analysis (role not qualified) Also mentioned in 28 other decision(s): 10x Genomics v Curio Bioscience (CFI, ORD_598272/2023, 30 April 2024) · 10x Genomics v Curio Bioscience (CFI, UPC_CFI_658/2025, 2 February 202 · 10x Genomics v Curio Bioscience (CFI, UPC_CFI_657/2025, 2 February 202 · 10x Genomics v Curio Bioscience (CFI, 5 August 2025) · 10x Genomics v Curio Bioscience (CFI, 4 August 2025) · 10x Genomics v Curio Bioscience (CFI, 16 June 2025) · 10x Genomics v Curio Bioscience (CFI, 4 June 2025) · 10x Genomics v Curio Bioscience (CFI, 2 May 2025) | not recorded | not recorded | not recorded | Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.